Cargando…

Cardiac pathology in spinal muscular atrophy: a systematic review

BACKGROUND: Hereditary proximal spinal muscular atrophy (SMA) is a severe neuromuscular disease of childhood caused by homozygous loss of function of the survival motor neuron (SMN) 1 gene. The presence of a second, nearly identical SMN gene (SMN2) in the human genome ensures production of residual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijngaarde, C. A., Blank, A. C., Stam, M., Wadman, R. I., van den Berg, L. H., van der Pol, W. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387385/ https://www.ncbi.nlm.nih.gov/pubmed/28399889 http://dx.doi.org/10.1186/s13023-017-0613-5

Ejemplares similares

A continuous repetitive task to detect fatigability in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2018)

Limited maximal mouth opening in patients with spinal muscular atrophy complicates endotracheal intubation: An observational study
por: Wijngaarde, Camiel A., et al.
Publicado: (2018)

Natural history of lung function in spinal muscular atrophy
por: Wijngaarde, Camiel A., et al.
Publicado: (2020)

Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy
por: Wadman, Renske I, et al.
Publicado: (2020)

A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls
por: Wadman, Renske I., et al.
Publicado: (2016)

Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests
por: Bartels, Bart, et al.
Publicado: (2019)

Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests
por: Bartels, Bart, et al.
Publicado: (2020)

Quantitative MRI of skeletal muscle in a cross‐sectional cohort of patients with spinal muscular atrophy types 2 and 3
por: Otto, Louise A.M., et al.
Publicado: (2020)

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4
por: Stam, Marloes, et al.
Publicado: (2022)

Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy
por: Wadman, Renske I., et al.
Publicado: (2019)

Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study
por: Veldhoen, Esther S., et al.
Publicado: (2022)

Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2019)

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
por: Stam, Marloes, et al.
Publicado: (2018)

Relative hyperventilation in non-ventilated patients with spinal muscular atrophy
por: Veldhoen, Esther S., et al.
Publicado: (2020)

Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study
por: Veldhoen, Esther S., et al.
Publicado: (2023)

Feasibility and tolerability of multimodal peripheral electrophysiological techniques in a cohort of patients with spinal muscular atrophy
por: Ros, Leandra A.A., et al.
Publicado: (2023)

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study
por: Scheijmans, Féline E V, et al.
Publicado: (2022)

Mastication in Patients with Spinal Muscular Atrophy Types 2 and 3 is Characterized by Abnormal Efficiency, Reduced Endurance, and Fatigue
por: van der Heul, A. M. B., et al.
Publicado: (2021)

Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study
por: Otto, Louise A.M., et al.
Publicado: (2021)

Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy
por: Habets, Laura E, et al.
Publicado: (2021)

Innovating spinal muscular atrophy models in the therapeutic era
por: Signoria, Ilaria, et al.
Publicado: (2023)

Parents’ perspectives on nusinersen treatment for children with spinal muscular atrophy
por: van Kruijsbergen, Mette, et al.
Publicado: (2021)

Respiratory muscle fatigability in patients with spinal muscular atrophy
por: Kant‐Smits, Kim, et al.
Publicado: (2022)

Multi‐parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophy
por: Hooijmans, Melissa T., et al.
Publicado: (2022)

SMN1 Duplications Are Associated With Progressive Muscular Atrophy, but Not With Multifocal Motor Neuropathy and Primary Lateral Sclerosis
por: Bos, Jeroen W., et al.
Publicado: (2021)

Cardiac involvement in patients with Spinal Muscular Atrophies
por: Palladino, Alberto, et al.
Publicado: (2011)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol
por: Ros, Leandra A. A., et al.
Publicado: (2023)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice
por: Galbiati, Mariarita, et al.
Publicado: (2023)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

‘This battle, between your gut feeling and your mind. Try to find the right balance’: Parental experiences of children with spinal muscular atrophy during COVID‐19 pandemic
por: Oude Lansink, Irene L. B., et al.
Publicado: (2022)

Emerging therapies and challenges in spinal muscular atrophy
por: Farrar, Michelle A., et al.
Publicado: (2017)

Muscular Atrophies: A Clinico-Pathological Study
por: Krauss, William C.
Publicado: (1891)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iqus4o69u56pbq0jtanhbco22i